FEATURES OF RESPIRATORY SUPPORT FOR PATIENTS WITH PNEUMONIA IN THE CONTEXT OF THE COVID-19 PANDEMIC
Introduction: The coronavirus infection (COVID-19) pandemic is at its peak. Since the beginning of the pandemic, the understanding of nosology has been growing every day. Although large randomized trials are underway, treatment is based on supportive care. Current recommendations are based on the treatment of other viral pneumonias and sepsis. But the course of COVID-19 is very different from them.
Aim – analysis of articles on respiratory support for coronavirus infection COVID-19 published in the most authoritative evidence-based sources.
Search strategy: the search was carried out in the following databases - PubMed, Google Scholar, Scopus, Embase. The initial number of articles - 325 (including duplicate articles - 188), titles and abstracts of articles - 137 were studied (including 63 articles were excluded for the following reasons - lack of a comparison group, inconsistency of goals and titles of articles). Fully studied articles - 74 (including 39 articles were excluded for the following reasons - the lack of randomization of patients, the presence of methodological errors). The number of articles included in the study is 35.
Results: the main task in the treatment of acute respiratory failure is adequate oxygenation, since hypoxia can lead to severe and irreparable functional disorders. In patients with COVID-19, oxygen therapy and respiratory support should begin prior to admission to intensive care. The most accessible in the treatment of acute respiratory failure is oxygen therapy.
Conclusions. The COVID-19 pandemic requires an expanded and comprehensive analysis of the risks and benefits of respiratory support, including NIV and mechanical ventilation. Respiratory support with modern options for oxygen therapy and NIV will require a careful assessment of the risks of infection of healthcare workers, nosocomial spread of infection, the availability of healthcare resources and the clinical spectrum of diseases in comorbid patients with COVID-19.
Venera Israilova1, https://orcid.org/0000-0001-7778-9618
Galym Aitkozhin1, https://orcid.org/0000-0001-8787-922Х
Mirkhoshim Mirsaliyev1, https://orcid.org/0000-0001-5166-6169
Dana Kozhamberdiyeva2, Umida Akhmejanova1
1 JSC “Asfendiyarov Kazakh National Medical University”, Department of anesthesiology and resuscitation, Almaty c., Republic of Kazakhstan;
2 City Clinical Hospital №1, Almaty c., Republic of Kazakhstan.
1. Al-Lami R.A., Urban R.J., Volpi E., et al. Sex hormones and novel corona virus infectious disease (COVID-19) // Mayo Clin Proc. 2020. 95(8):1710-4.
2. Armstrong R.A., Kane A.D., Cook T.M. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies // Anaesthesia. 2020, published online June 30. (accessed: 20.10.2021)
3. Barochiner J., Martínez R. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and metaanalysis // J Clin Pharm Ther., 2020, published online Aug 7. (accessed: 22.10.2021)
4. Capuano A., Rossi F., Paolisso G. Covid-19 kills more men than women: an overview of possible reasons // Front Cardiovasc Med., 2020. 7:131.
5. Drucker D.J. Coronavirus infections and type 2 diabetes - shared pathways with therapeutic implications // Endocr Rev. 2020. 41(3):bnaa011.
6. Falaschi Z., Danna P.S.C., Arioli R., et al. Chest CT accuracy in diagnosing COVID-19 during the peak of the Italian epidemic: A retrospective correlation with RT-PCR testing and analysis of discordant cases // Eur J Radiol 2020. 130: 109-192.
7. Folegatti P.M., Ewer K.J., Aley P.K., et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial // Lancet. 2020. published online July 20. https://doi.org/10.1016/S0140-6736(20)31604-4. (accessed: 18.10.2021)
8. Gottlieb M., Sansom S., Frankenberger C., et al. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois // Acad Emerg Med. 2020, 2020. 10.1111. acem.14104 published online Aug 6. (accessed: 18.10.2021)
9. Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020, published online April 6. doi:10.1001/jama.2020.5394 .
10. Guan W.J., Ni Z.Y., Hu Y., et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China // N Engl J Med. 2020. 382(18):1708-20.
11. Hermans J.J.R., Groen J., Zwets E., et al. Chest CT for triage during COVID-19 on the emergency department: myth or truth? // Emerg Radiol. 2020. published online Jul 20. (accessed: 23.10.2021)
12. Hippisley-Cox J., Young D., Coupland C., et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3. // Heart. 2020 Oct;106(19):1503-1511. doi: 10.1136/heartjnl-2020-317393. Epub 2020 Jul 31. (accessed: 15.10.2021)
13. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. 395(10223):497-506.
14. Jackson L.A., Anderson E.J., Rouphael N.G., et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report // N Engl J Med. 2020. published online July 14. doi:10.1056/NEJMoa2022483
15. Li H., Liu L., Zhang D., et al. SARS-CoV-2 and viral sepsis: observations and hypotheses // Lancet. 2020. 395(10235):1517-20.
16. Liang X., Shi L., Wang Y., et al. The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates // J Infect. 2020. 81(3):e44–7.
17. Lighter J., Phillips M., Hochman S., et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission // Clin Infect Dis. 2020. 71:896-97.
18. Logunov D.Y., Dolzhikova I.V., Zubkova O.V., et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia // The Lancet 2020; Published Online September 4. https://doi.org/10.1016/S0140-6736(20)31866-3. (accessed: 14.10.2021)
19. Lurie N., Sharfstein J.M., Goodman J.L. The development of COVID-19 vaccines: safeguards needed // JAMA, 2020. published online July 6. https://doi.org.10.1001/jama.2020.12461. (accessed: 17.10.2021)
20. Petrilli C.M., Jones S.A., Yang J., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study // BMJ 2020. 369:m1966.
21. Phelan A.L., Katz R., Gostin L.O. The novel coronavirus originating in Wuhan, China: challenges for global health governance // JAMA, 2020. published online Jan 30. DOI:10.1001/jama.2020.1097. (accessed: 21.10.2021)
22. Pillay T.S. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein // J Clin Pathol. 2020. 73(7):366-9.
23. Quah P., Li A., Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature // Critical Care. 2020. 24: 285.
24. Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area // JAMA. 2020. 323:2052-9.
25. Salehi S., Abedi A., Balakrishnan S., Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 Patients // AJR Am J Roentgenol. 2020. 215(1):87-93.
26. Schulze-Hagen M., Hübel C., Meier-Schroers M., et al. Low-dose chest CT for the diagnosis of COVID-19 // Dtsch Arztebl Int. 2020. 117(22-23):389-95.
27. Scully E.P., Haverfield J., Ursin R.L., et al. Considering how biological sex impacts immune responses and COVID-19 outcomes // Nat Rev Immunol. 2020. 20:442–7.
28. Vaduganathan M., Vardeny O., Michel T., et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19 // N Engl J Med. 2020. 82:1653-9.
29. Wang D., Hu B., Hu C., et al. Clinical сharacteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China // JAMA 2020. 323(11):1061-9.
30. Wendel Garcia P.D., Fumeaux T., Guerci P., et al. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort // E Clinical Medicine. 2020. 4:26.
31. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China // JAMA Intern Med. 2020. 180(7):1-11.
32. Wu Z., Mc Googan J.M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention // JAMA. 2020 published online Feb 24. doi: 10.1001/jama.2020.2648. (accessed: 15.10.2021)
33. Xiong T.Y., Huang F.Y., Liu Q., et al. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study // Ann Med. 2020 published online Jul 27. doi: 10.1080/07853890.2020.1802059. (accessed: 18.10.2021)
34. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet 2020. 395:1054–62.
35. Zhu F.C., Guan X.H., Li Y.H., et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebocontrolled, phase 2 trial // Lancet. 2020. published online July 20. https://doi.org/10.1016/S0140-6736(20)31605-6. (accessed: 18.10.2021)
Number of Views: 157
Category of articles:
COVID-19 - Topical Subject
Bibliography link
Israilova V., Aitkozhin G., Mirsaliyev M., Kozhamberdiyeva D., Akhmejanova U. Features of respiratory support for patients with pneumonia in the context of the COVID-19 pandemic // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 1, pp. 14-21. doi 10.34689/SH.2022.24.1.002Related publications:
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
APPLICATION OF ARTIFICIAL INTELLIGENCE IN COMBATING THE COVID-19 PANDEMIC: CURRENT TRENDS AND PROSPECTS. REVIEW
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW
FEATURES OF THE SICKNESS BEHAVIOR OF ARTERIAL HYPERTENSION AND OBESITY DURING THE PANDEMIC OF COVID-19 CORONAVIRUS. REVIEW